SCHEMBL29567055

SCHEMBL29567055

Cc1ccccc1Oc1nc(NS(=O)(=O)c2cnn(C)c2)nc(Cl)c1C1CC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 12/20 0.40
▸ HTR7 P34969 12/20 0.40
▸ DRD2 P14416 5/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ THRB P10828 1/20 0.34
▸ HTR2A P28223 4/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ MAP3K7 O43318 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAP2K1 Q02750 1/20 0.33
▸ PCK1 P35558 1/20 0.33
▸ SCD O00767 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ SLC8A1 P32418 1/20 0.32
▸ APLNR P35414 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309427 1.00 HTR1A (0.40) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29567792 0.87 HTR1A (0.39) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309426 0.87 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24310759 0.87 HTR1A (0.39) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29566383 0.84 HTR1A (0.36) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24310130 0.84 HTR1A (0.36) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29566971 0.83 HTR1A (0.37) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309646 0.83 HTR1A (0.37) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309457 0.83 HTR1A (0.39) HTR1AHTR7DRD2HTR6HTR2A
SCHEMBL24309435 0.83 PDE10A (0.38) HTR1AHTR7DRD2HTR6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback